Important advances have allowed us to develop treatment options that potent biological responses, mainly in the immune system.
Canova can be a great ally for doctors when indicated along with conventional treatments, offering their patients a relief of the diseases’ symptoms and absence of side effects of these treatments, also with a higher medicinal efficacy.
The growth of knowledge in immunology clinical has revealed the pathophysiology of diseases caused by exacerbation of immune response and immune deficiencies in several areas of medicine. The modern immune therapy involves the use of immunomodulators. Drugs that can exacerbate or reduce the immune response, with topical or systemic use, for the treatment of diseases caused by immunodeficiency or hypersensitivity.
It´s well known as in science as layperson that these treatments manipulate, change and explore the immune response. Most immunomodulators arose empirically. Recently, with the development of the comprehension of pathophysiology of immune system, new immunomodulatory were developed with more rational system. Several publications about these groups of drugs have shown the importance of these therapies as essential in pharmacotherapy of doctor in any medicine´s area.
Canova has been recognized as biological response modifiers (BRM). The BRM may act, for example, in mediating the activity of macrophages from the complement system and the mechanisms of cell adhesion.
In this context and with all these assumptions, we present Canova®, a medicament largely studied that could help countless people which immune system is compromised, reaching all that science seeks: provide all patients a decent life quality.